Main Article Content
Down syndrome (DS) is a genetic disorder that occurs due to trisomy on chromosome 21. It is known to relate to the amyloid-beta (A4) precursor protein (APP) gene and amyloid plaques, affecting developmental processes and resulting in early dementia, signifying a relation to Alzheimer's disease (AD). AD in individuals with DS affects many aspects include memory function, social and cognitive behavior. There is also a high likelihood for individuals with DS to have an AD at an early age, adding more challenges to the patients and the caregivers. Triplication of the gene in DS and an extra copy of APP in familial AD patients are responsible for the genetic link between these two diseases.
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.